Aligos Therapeutics
ALGS4.7400.21% ( -0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Aligos Therapeutics(ALGS) predict that the Revenue is 2.83 M (+810%), Beat estimate;the EBIT is -26.93 M (-39.94%), Miss estimate;the EPS is -2.21 (-143.2%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B809.97%
0.00B7.18%
+0.00B802.79%
EBITMiss expectations
-0.03B39.94%
-0.02B26.56%
-0.00B13.38%
EPSExceed expectations
-2.21143.16%
-2.25143.95%
+0.04000.79%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue13.18 M
Estimate EBIT-17.19 M
Estimate EPS-1.184
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf